Summary
This prediction ended on 07.12.24 with a price of €8.75. The SELL prediction by nvestor shows the price for Evotec SE slightly increased by 2.70% during the runtime of the prediction. nvestor has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Evotec SE | -4.205% | -4.205% | -39.977% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to nvestor what are the pros and cons of Evotec SE for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Bad rating
Risky balance sheet
ROE lower than 10% per year
Below average Management
Bad culture
Little innovation
Few uniques
Growths slower than the competition
high free float
Higher risks for its business
Below average Marketposition
Business model of the past or high risk
Lower EBIT Margin than peer group
Low dividend yield expected
Little Investments for future growth
Sustainability is little important
Little known brand
negative Cash Flow expected
Increased challenges to pay loans and raise capital
Dependend from some customers or products
Significant cyclical dependencies
Comments by nvestor for this prediction
In the thread Evotec AG diskutieren
In the thread Trading Evotec AG
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.